Metabolic Syndrome May Exacerbate Macular and Retinal Damage in Psoriasis Vulgaris

REFERENCES

• Loureiro M, Braga AC, Meira D, Sepulveda P, Agrelos L, Torres P. Peripapillary choroidal thickness by enhanced depth imaging optical coherence tomography: The impact of metabolic syndrome. Eur J Ophthalmol. 2017;27(4):428–432.
   Web of Science ®Google Scholar
• Yokomichi H, Kashiwagi K, Kitamura K, Yoda Y, Tsuji M, Mochizuki M, ... Yamagata Z. Evaluation of the associations between changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study in Japan. BMJ Open. 2016;6(3):e010360.
   PubMed Web of Science ®Google Scholar
• De Souza-Junior JE, Garcia CA, Soares EM, Maranhao TM, Lemos TM, Azevedo GD. Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography. J Ophthalmol. 2015;2015:193078.
   PubMed Web of Science ®Google Scholar
• Abbouda A, Abicca I, Fabiani C, Scappatura N, Peña-Garcia P, Scrivo R, ... Paroli MP. Psoriasis and psoriatic arthritis-related uveitis: Different ophthalmological manifestations and ocular inflammation features. Semin Ophthalmol. 2017;32(6):715–720.
   Web of Science ®Google Scholar
• Ersan I, Kilic S, Arikan S, Kara S, Isik S, Gencer B, Ogretmen Z. Evaluation of macular ganglion cell-inner plexiform layer and choroid in psoriasis patients using enhanced depth imaging spectral domain optical coherence tomography. Ocul Immunol Inflamm. 2017;25(4):520–524.
   Web of Science ®Google Scholar
• Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Curr Pharm Des. 2014;20:513–528.
   PubMed Web of Science ®Google Scholar
• Karbach S, Croxford AL, Oelze M, Schüler R, Minwegen D, Wegner J, ... Münzel T. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol. 2014;34(12):2658–2668.
   PubMed Web of Science ®Google Scholar
• Heng D, Ma S, Lee JJ, Tai BC, Mak KH, Hughes K, ... Tai ES. Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis. 2006;186(2):367–373.
   PubMed Web of Science ®Google Scholar
• Ku SH, Kwon WJ, Cho EB, Park EJ, Kim KH, Kim KJ. The association between psoriasis area and severity index and cardiovascular risk factor in Korean psoriasis patients. Ann Dermatol. 2016;28:360–363.
   PubMed Web of Science ®Google Scholar
• Bastard JP, Grimaldi A, Jardel C, Porquet D, Bruckert E, Hainque B. A simple index of insulin resistance. Diabetes Metab. 1997;23:87–88.
   PubMed Web of Science ®Google Scholar
• Heidenreich R, Rocken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol. 2009;90:232–248.
   PubMed Web of Science ®Google Scholar
• Boehncke S, Thaci D, Beschmann H, Ludwig RJ, Ackermann H, Badenhoop K, Boehncke WH. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007;157(6):1249–1251.
   PubMed Web of Science ®Google Scholar
• Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127:1–4.
   PubMed Web of Science ®Google Scholar
• Paniagua JA. Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. World J Diabetes. 2016;7:483–514.
   PubMed Web of Science ®Google Scholar
• Bruno RM, Reesink KD, Ghiadoni L. Advances in the non-invasive assessment of vascular dysfunction in metabolic syndrome and diabetes: focus on endothelium, carotid mechanics and renal vessels. Nutr Metab Cardiovasc Dis. 2017;27:121–128.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68:654–662.
   PubMed Web of Science ®Google Scholar
• Singh S, Young P, Armstrong AW. Relationship between psoriasis and metabolic syndrome: a systematic review. G Ital Dermatol Venereol. 2016;151:663–677.
   PubMed Web of Science ®Google Scholar
• Canavese M, Altruda F, Ruzicka T, Schauber J. Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis–a possible target for novel therapies? J Dermatol Sci. 2010;58:171–176.
   PubMed Web of Science ®Google Scholar
• Berger S, Savitz SI, Nijhawan S, Singh M, David J, Rosenbaum PS, Rosenbaum DM. Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2008;49(8):3605–3610.
   PubMed Web of Science ®Google Scholar
• Kitaoka Y, Kitaoka Y, Kwong JM, Ross-Cisneros FN, Wang J, Tsai RK, ... Lam TT. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci. 2006;47(4):1448–1457.
   PubMed Web of Science ®Google Scholar
• Knier B, Rothhammer V, Heink S, Puk O, Graw J, Hemmer B, Korn T. Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis. J Autoimmun. 2015;56:34–44.
   PubMed Web of Science ®Google Scholar
• Shi R, Guo Z, Wang F, Li R, Zhao L, Lin R. Alterations in retinal nerve fiber layer thickness in early stages of diabetic retinopathy and potential risk factors. Curr Eye Res. 2017;7:1–10.
   Google Scholar
• Zarei R, Anvari P, Eslami Y, Fakhraie G, Mohammadi M, Jamali A, ... Moghimi S. Retinal nerve fiber layer thickness is reduced in metabolic syndrome. Diabet. Med. 2017;34:1061–1066.
   PubMed Web of Science ®Google Scholar